Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AspiAir is a medical technology company specializing in the development of advanced respiratory drug delivery systems. The company's flagship product is a high-performance, portable vibrating mesh nebulizer designed to provide efficient and consistent aerosol therapy for patients with chronic respiratory conditions such as asthma and COPD. AspiAir focuses on improving patient compliance and treatment outcomes through silent, lightweight, and easy-to-use devices that allow for effective medication delivery on the go. Their technology is engineered to handle a wide range of medications, including biologics and suspensions, with minimal residual volume.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aspiair.